Singapore · Series C startup

Who invested in MerLion Pharmaceuticals

One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Funding summaryUpdated 26 Oct 2026

$7.0Mraised across 1 round since 2010, from 1 source

Latest round
Series C, $7.0MOct 2010
Investors
3
See who backed them

The rounds

  1. Oct 2010

Everyone who backed them

Bio*One CapitalCorporate VC1round
Aravis VenturesPrivate equity1round
Aurelia Private EquityGrowth equity1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about MerLion Pharmaceuticals

Who invested in MerLion Pharmaceuticals?

MerLion Pharmaceuticals's investors include Bio*One Capital, Aravis Ventures and Aurelia Private Equity.

How much has MerLion Pharmaceuticals raised?

MerLion Pharmaceuticals has raised $7.0M across 1 round since 2010.

When did MerLion Pharmaceuticals last raise?

MerLion Pharmaceuticals's most recent round was a Series C of $7.0M in Oct 2010.

What was MerLion Pharmaceuticals's biggest round?

Its most recent round, $7.0M in Oct 2010, is also its largest on record.

Who backed MerLion Pharmaceuticals first?

MerLion Pharmaceuticals's first round on record, in Oct 2010, was backed by Bio*One Capital, Aravis Ventures and Aurelia Private Equity.

What stage is MerLion Pharmaceuticals at?

MerLion Pharmaceuticals's latest named round is a Series C, in Oct 2010.

Where is MerLion Pharmaceuticals based?

MerLion Pharmaceuticals is based in Singapore.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.